Just Other Articles
#1 in Business Subscribe Email Print

You are here: Home > Internet and Businesses Online > Ezine Publishing > Ezine Publishing; Be Careful of Filler Content

Tags

  • industry
  • paragraph
  • irrelevant
  • combination products
  • companies involved

  • Links

  • We're Good at the Things We Like
  • Work Place Communication in Air Transportation Sector
  • How You Can Use Portable GPS Units
  • Just Other Articles - Ezine Publishing; Be Careful of Filler Content

    One of the reasons that Ezines and all online newsletters do so well
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    is because people are upset at the trade journals, which seem to ha
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    e so many filler pages of worthless content that many of the subscri
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ers are no longer interested. You have probably seen in many indust
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    y trade journals where the articles are somewhat irrelevant to the i
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    dustry yet in the first paragraph and the last paragraph it appears
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    hat the articles have been modified in order to get the classificati
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    n of that particular industry sector.

    It doesn't take a rocket scie
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    tist or someone in an industry to recognize that these articles are
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    asically BS and merely public relations pieces in order to sell them
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    something and therefore they flip through theses trade journals very
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    quickly without reading them. Further this hurts the advertisers be
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ause the subscriber is also flipping past the advertising.

    If a tra
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    e journal has too few articles in it and the magazine is not very th
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ck people do not value it, but too much filler and people no longer
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ave any value added. This same problem applies to Ezine Publishing
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    nd we see all too often that there are articles, which are completel
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    worthless to the subject matter of the Ezine or are so basic that t
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ey are irrelevant to the reader. Therefore, Ezine Publishers need to
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    be very careful of such Filler Content. Please consider this in 2006


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justotherarticles.org.ua/article/63359/justotherarticles-Ezine-Publishing-Be-Careful-of-Filler-Content.html">Ezine Publishing; Be Careful of Filler Content</a>

    BB link (for phorums):
    [url=http://www.justotherarticles.org.ua/article/63359/justotherarticles-Ezine-Publishing-Be-Careful-of-Filler-Content.html]Ezine Publishing; Be Careful of Filler Content[/url]

    Related Articles:

    Ego and Advertising Do Not Mix

    The Power of Agreeability: Part One

    Direct Sales and the Use of Clipboards

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com